4 Followers on Owler
OverviewCompetitorsFundingNews & Insights

TFF Pharmaceuticals Funding History

Since TFF Pharmaceuticals was founded in 2018, it has participated in 10 rounds of funding. In total TFF Pharmaceuticals has raised $107.1M. TFF Pharmaceuticals' last funding round was on Apr 2024 for a total of $4.8M.

TFF Pharmaceuticals Funding Rounds

Unlock 7 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Post-IPO Equity
Apr 2024
$4.8M
__
Post-IPO Equity
Mar 2024
$1.2M
__
Post-IPO Equity
Aug 2023
$5.7M
__
Grant
Jun 2023
$3M
1
National Institute of Allergy and Infectious Diseases
Post-IPO Equity
Nov 2022
$12.3M
__

Total Funding: $107.1M

TFF Pharmaceuticals Investors

INVESTOR

ROUND

FUNDING DATE

National Institute of Allergy and Infectious Diseases
Grant
Jun 2023
Liquid Venture Partners
Series A
Apr 2018

Total Investors: 2

TFF Pharmaceuticals has 2 investors, including National Institute of Allergy and Infectious Diseases and Liquid Venture Partners. The latest investment occurred in Apr 2024.